Category:

Health

Latest

Expert panel clears Bharat Biotech’s vaccine for restricted emergency use

Covaxin has been indigenously developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

The Subject Expert Committee (SEC) on COVID-19 of the Central Drugs Standard Control Organisation (CDSCO) on Saturday again deliberated on the emergency use authorisation (EUA) application of the Hyderabad-based pharmaceutical firm after it submitted additional data, facts and analysis subsequent to Friday’s review meeting, a source said.

read more

More than 50 countries launch Covid-19 vaccination campaigns

In Asia, Singapore launched its campaign on Wednesday with the same vaccine.

Other countries on the Asian continent however have decided to take their time: India, Japan and Taiwan plan to begin vaccinations in the first quarter of 2021 and the Philippines and Pakistan in the second quarter, while Afghanistan and Thailand plan to start in mid-2021.

read more

All passengers from UK to be tested for COVID-19 on arrival between Jan 8-Jan 30: Health ministry

If a passenger tests COVID-positive on arrival, passengers seated in the same row, three rows in front and three rows behind would also be subjected to institutional quarantine in separate quarantine centers, the SOP said.

The passengers who are found COVID-negative after the tests conducted at the airport would be advised home quarantine for 14 days and the concerned state or district administration should regularly follow up with them, it said.

read more

India records less than 20,000 fresh COVID-19 cases; no. of recoveries goes past 99 lakh

The number of people who have recuperated from the disease surged to 99,06,387, pushing the national recovery rate to 96.12 per cent, while the COVID-19 case fatality rate stood at 1.45 per cent.

There are 2,50,183 active coronavirus cases in the country, which accounts for 2.43 per cent of the total caseload, the data stated.

read more

Have to assume pandemic is going to get worse: Fauci

Fauci’s comments on Tuesday came after the US registered a record high 65,000 deaths in the past 28 days, making December the worst month for coronavirus fatalities since the start of the pandemic.

December’s figure, roughly equivalent to over 1.6 Americans lost to the virus every minute, marked a significant surge from that in the entire month of November which registered 36,964 fatalities.

The country’s overall the overall death toll currently stood at 338,544, the highest in the world, according to the Johns Hopkins University.

read more

Study uncovers blood vessel damage, inflammation in COVID-19 patients’ brains

The researchers saw no signs of infection in the brain tissue samples even though they used several methods for detecting genetic material or proteins from SARS-CoV-2.

“So far, our results suggest that the damage we saw may not have been not caused by the SARS-CoV-2 virus directly infecting the brain,” said Dr. Nath. “In the future, we plan to study how COVID-19 harms the brain’s blood vessels and whether that produces some of the short- and long-term symptoms we see in patients.”

read more

India drug regulator approves AstraZeneca COVID vaccine, country’s first

Cheaper and easier to distribute than rival shots, the AstraZeneca/Oxford vaccine could be a game-changer for global immunisation.
The Central Drugs Standard Control Organization is also considering emergency-use authorisation applications for vaccines made by Pfizer Inc with Germany’s BioNTech, and by India’s Bharat Biotech.
India wants to start administering the vaccine soon, most likely by Wednesday, said one of the sources, both of whom declined to be named ahead of an official announcement expected later in the day.

read more

WHO emergency COVID-19 vaccine listing aims to lift access in poor countries

The United Nations health agency said it will work with regional partners to tell national health authorities about the two-dose shot and its anticipated benefits.

The WHO established its emergency use listing (EUL) process to help poorer countries without their own regulatory resources quickly approve medicines new diseases like COVID-19, which otherwise could lead to delays.

read more

Drugmakers to hike prices for 2021 as pandemic, political pressure put revenues at risk

President-elect Biden has also vowed to reduce drug costs and to allow Medicare, a U.S. government health insurance program, to negotiate drug prices. He has support from Congressional Democrats to pass such legislation, which the Congressional Budget Office has said could cost the industry more than $300 billion by 2029.

read more